ArticleJournal of mathematical biology2026
A framework for jointly modeling the natural history of ductal carcinoma in situ and invasive breast cancer.
Article in Journal of mathematical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
We present a new approach for jointly modelling the natural history of ductal carcinoma in situ (DCIS) and invasive breast cancer, based on a continuous tumor growth framework. We first describe the structure of a stable disease population, in which individuals traverse with rates invariant to calendar time through different health states. Based on the properties of this population we develop a likelihood model that jointly utilizes probability distributions describing sub-models for screening sensitivity, detection through symptoms, tumor growth rate and time for DCIS to become invasive. This model can incorporate any parametric forms for these sub-models, allowing for testing different assumptions for the occult biological progression of breast cancer. By using stable disease assumptions the model can be fitted to data from incident cancer cases and does not require specification of a sub-model for age at tumour onset. In the final part of the publication we perform simulations to verify the theoretical properties of the stable disease population and to show how our model can be used in a real setting to estimate characteristics of the involved latent processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.